# Bluejay Diagnostics Inc. (BJDX)

Source: https://www.quantisnow.com/company/BJDX
Generated: 2026-10-29T15:27:21.602Z

- Ticker: BJDX
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Medical/Dental Instruments
- IPO year: 2021
- SEC CIK: 0001704287
- Website: bluejaydx.com

## About

Bluejay Diagnostics, Inc., an in-vitro diagnostic company, develops, manufactures, and markets minimally invasive point-of-care (POC) diagnostics tests and devices for infectious disease, inflammation, and oncology markets in the United States. It is developing Symphony biomarker detection platform for the detection of sepsis, cancer, cardiac ishcemia, and congestive heart failure. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis. It has a collaboration agreement with Toray Industries, Inc. to develop a point of care test for covid-19 patient triage; and a research and development agreement with Naval Medical Research Center to develop lateral flow rapid test for diagnosis of various tick-borne diseases, including Lyme disease. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.

## Latest BJDX news and filings

- 2026-10-13 13:09 UTC [SEC Form 8-K] [SEC Form 8-K filed by Bluejay Diagnostics Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-bluejay-diagnostics-inc-6744583)
- 2026-10-13 10:30 UTC [Market Insight] [Bluejay Achieves Toray Contractual Manufacturing Milestone, Advancing Supply-Chain Resilience and Commercialization Readiness](https://www.quantisnow.com/insight/bluejay-achieves-toray-contractual-manufacturing-milestone-advancing-supply-chain-resilience-and-6743975)
- 2026-10-06 13:04 UTC [SEC Form 8-K] [SEC Form 8-K filed by Bluejay Diagnostics Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-bluejay-diagnostics-inc-6738493)
- 2026-10-06 10:30 UTC [Market Insight] [Bluejay Diagnostics Announces SYMON-II Clinical Dataset Details Supporting Evaluation of Mortality Risk in Sepsis and Septic Shock](https://www.quantisnow.com/insight/bluejay-diagnostics-announces-symon-ii-clinical-dataset-details-supporting-evaluation-of-6737986)
- 2026-09-08 20:50 UTC [SEC Form 8-K] [Bluejay Diagnostics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/bluejay-diagnostics-inc-filed-sec-form-8-k-entry-into-a-6708599)
- 2026-09-08 10:30 UTC [Conference Announcement] [Bluejay Diagnostics and Lovell Government Services Announce Partnership to Expand Access to U.S. Federal Healthcare Markets](https://www.quantisnow.com/insight/bluejay-diagnostics-and-lovell-government-services-announce-partnership-to-expand-6707302)
- 2026-08-18 20:15 UTC [SEC Form 4] [President and CEO Dey Indranil was granted 28,000 shares, increasing direct ownership by 224% to 40,522 units (SEC Form 4)](https://www.quantisnow.com/insight/president-and-ceo-dey-indranil-was-granted-28000-shares-increasing-6686694)
- 2026-08-18 20:15 UTC [SEC Form 4] [SEC Form 4 filed by Director Dey Svetlana](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-dey-svetlana-6686693)
- 2026-08-18 20:16 UTC [SEC Form 4] [SEC Form 4 filed by Director Wurth Douglas Clark](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-wurth-douglas-clark-6686690)
- 2026-08-18 20:16 UTC [SEC Form 4] [SEC Form 4 filed by Director Zeidman Fred S](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-zeidman-fred-s-6686681)
- 2026-08-18 20:15 UTC [SEC Form 4] [SEC Form 4 filed by Director Chase Donald R](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-chase-donald-r-6686669)
- 2026-08-14 14:03 UTC [SEC Form SCHEDULE 13G filed by Bluejay Diagnostics Inc.](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-bluejay-diagnostics-inc-6682206)
- 2026-08-13 16:27 UTC [SEC Form SCHEDULE 13G filed by Bluejay Diagnostics Inc.](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-bluejay-diagnostics-inc-6679871)
- 2026-08-13 11:56 UTC [SEC Form 8-K] [Bluejay Diagnostics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/bluejay-diagnostics-inc-filed-sec-form-8-k-regulation-fd-disclosure-6679342)
- 2026-08-13 10:00 UTC [Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony™ IL-6 Toward Regulatory Submission and Commercialization](https://www.quantisnow.com/insight/bluejay-diagnostics-reports-q2-2026-results-strengthened-balance-sheet-supports-6678944)
- 2026-08-12 20:41 UTC [SEC Form S-8] [SEC Form S-8 filed by Bluejay Diagnostics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-filed-by-bluejay-diagnostics-inc-6678308)
- 2026-08-12 20:05 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Bluejay Diagnostics Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-bluejay-diagnostics-inc-6677845)
- 2026-07-22 21:25 UTC [SEC Form 8-K] [Bluejay Diagnostics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/bluejay-diagnostics-inc-filed-sec-form-8-k-regulation-fd-disclosure-6645748)
- 2026-07-22 17:38 UTC [SEC Form 4] [SEC Form 4 filed by Large owner Bank Of America Corp /De/](https://www.quantisnow.com/insight/sec-form-4-filed-by-large-owner-bank-of-america-6645009)
- 2026-07-22 17:29 UTC [SEC Form 3] [New insider Bank Of America Corp /De/ claimed ownership of 8 shares (SEC Form 3)](https://www.quantisnow.com/insight/new-insider-bank-of-america-corp-de-claimed-ownership-of-6645002)
- 2026-07-21 10:30 UTC [Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study](https://www.quantisnow.com/insight/bluejay-diagnostics-announces-successful-completion-of-enrollment-in-the-symon-ii-6643068)
- 2026-07-13 19:14 UTC [Insider Buy] [Large owner Hrt Financial Lp bought $96,711 worth of shares (64,047 units at $1.51) and sold $48,913 worth of shares (34,938 units at $1.40), increasing direct ownership by 46% to 92,055 units (SEC Form 4)](https://www.quantisnow.com/insight/large-owner-hrt-financial-lp-bought-96711-worth-of-shares-6635251)
- 2026-07-13 19:02 UTC [SEC Form 3] [New insider Hrt Financial Lp claimed ownership of 126,993 shares (SEC Form 3)](https://www.quantisnow.com/insight/new-insider-hrt-financial-lp-claimed-ownership-of-126993-shares-6635241)
- 2026-07-10 18:36 UTC [SEC Form 4] [SEC Form 4 filed by Large owner Bank Of America Corp /De/](https://www.quantisnow.com/insight/sec-form-4-filed-by-large-owner-bank-of-america-6633904)
- 2026-07-10 18:28 UTC [SEC Form 3] [New insider Bank Of America Corp /De/ claimed ownership of 8 shares (SEC Form 3)](https://www.quantisnow.com/insight/new-insider-bank-of-america-corp-de-claimed-ownership-of-6633897)
- 2026-06-29 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Bluejay Diagnostics Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-bluejay-diagnostics-inc-6618060)
- 2026-06-26 20:44 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Bluejay Diagnostics Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-bluejay-diagnostics-inc-6617623)
- 2026-06-17 21:20 UTC [SEC Form S-3] [SEC Form S-3 filed by Bluejay Diagnostics Inc.](https://www.quantisnow.com/insight/sec-form-s-3-filed-by-bluejay-diagnostics-inc-6607244)
- 2026-06-09 21:26 UTC [SEC Form 8-K] [Bluejay Diagnostics Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits](https://www.quantisnow.com/insight/bluejay-diagnostics-inc-filed-sec-form-8-k-leadership-update-submission-6595887)
- 2026-06-08 21:15 UTC [SEC Form 8-K] [Bluejay Diagnostics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/bluejay-diagnostics-inc-filed-sec-form-8-k-entry-into-a-6593911)
- 2026-06-06 00:13 UTC [Public Offering] [Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules](https://www.quantisnow.com/insight/bluejay-diagnostics-announces-closing-of-up-to-237-million-private-6592251)
- 2026-06-05 21:28 UTC [SEC Form SCHEDULE 13G filed by Bluejay Diagnostics Inc.](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-bluejay-diagnostics-inc-6591981)
- 2026-06-02 16:19 UTC [Bluejay Diagnostics Announces up to $23.6 Million Private Placement Priced At-the-Market Under Nasdaq Rules](https://www.quantisnow.com/insight/bluejay-diagnostics-announces-up-to-236-million-private-placement-priced-6583747)
- 2026-06-02 10:30 UTC [SEC Form 8-K] [Bluejay Diagnostics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/bluejay-diagnostics-inc-filed-sec-form-8-k-entry-into-a-6583030)
- 2026-06-02 10:30 UTC [Bluejay Diagnostics and Argonaut Manufacturing Services Announce Strategic Partnership](https://www.quantisnow.com/insight/bluejay-diagnostics-and-argonaut-manufacturing-services-announce-strategic-partnership-6583020)
- 2026-05-18 21:21 UTC [Insider Buy] [Director Wurth Douglas Clark bought $25,000 worth of shares (12,500 units at $2.00) (SEC Form 4)](https://www.quantisnow.com/insight/director-wurth-douglas-clark-bought-25000-worth-of-shares-12500-6560975)
- 2026-05-18 21:20 UTC [Insider Buy] [President and CEO Dey Indranil bought $25,000 worth of shares (12,500 units at $2.00), increasing direct ownership by 56,818% to 12,522 units (SEC Form 4)](https://www.quantisnow.com/insight/president-and-ceo-dey-indranil-bought-25000-worth-of-shares-6560972)
- 2026-05-18 21:20 UTC [Insider Buy] [Director Chase Donald R bought $25,000 worth of shares (12,500 units at $2.00), increasing direct ownership by 50,000% to 12,525 units (SEC Form 4)](https://www.quantisnow.com/insight/director-chase-donald-r-bought-25000-worth-of-shares-12500-6560967)
- 2026-05-18 21:19 UTC [Insider Buy] [Director Zeidman Fred S bought $25,000 worth of shares (12,500 units at $2.00) (SEC Form 4)](https://www.quantisnow.com/insight/director-zeidman-fred-s-bought-25000-worth-of-shares-12500-6560961)
- 2026-05-18 21:18 UTC [Insider Buy] [Director Dey Svetlana bought $25,000 worth of shares (12,500 units at $2.00), increasing direct ownership by 1,250,000% to 12,501 units (SEC Form 4)](https://www.quantisnow.com/insight/director-dey-svetlana-bought-25000-worth-of-shares-12500-units-6560958)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/BJDX
- RSS and alerts for BJDX: https://www.quantisnow.com/docs/rss-feeds.md